Test Detail
Influenza SARS-CoV-2 (Flu SC2) Multiplex
Back to Test Directory| Test Description |
|
||||
|---|---|---|---|---|---|
| Nucleic acid amplification by PCR to detect Influenza A and B virus RNA and SARS-CoV-2 RNA. | |||||
| Panel Components | |||||
| Influenza A RNA, Influenza B RNA, SARS-CoV-2 RNA | |||||
| Reflex Test(s) | |||||
| Influenza A Subtype by Polymerase Chain Reaction (PCR), Influenza B Subtype by Polymerase Chain Reaction (PCR), (SARS-CoV-2 by Next Generation Sequencing: results not reported to facility but will be reported to Iowa HHS and CDC.) | |||||
| Performed | Avg. Turnaround Time | Method | |||
| Coralville, 8 a.m. - 5 p.m., M-F |
1 - 5 business days | Nucleic Acid Amplification by Real-Time Polymerase Chain Reaction (PCR) | |||
| Fee | CPT Code(s) | ||||
| No charge. | 87798 | ||||
| Specimen Requirements | |||||
| Specimen Type: | Nasopharyngeal (NP) swab, Pooled Nasopharyngeal and Oropharyngeal swab, Throat swab, Nasal swab, Sputum, Tracheal aspirate, Bronchoalveolar lavage fluid (BAL), Bronchial brushings sample, Nasopharyngeal (NP) washings/aspirate, or Nasal wash/aspirate collected by a healthcare provider. PCR is a very sensitive test, and precautions should be taken to not cross-contaminate specimens (i.e., wear gloves and change before and after collecting specimen. Avoid contact with environmental surfaces). DO NOT FREEZE SPECIMEN. | ||||
| Collection Kits: | Collect specimen using a SHL Virus Isolation and Detection Kit (contains M4-RT viral transport medium and swabs) or equivalent viral transport medium.
Order Virus Isolation and Detection Kit at http://www.shl.uiowa.edu/kitsquotesforms/clinicalkit.xml. Collection instructions for upper and lower respiratory tract specimens are available on the CDC website at https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html. |
||||
| Collection Instructions: |
Nasopharyngeal (NP) Swab: A nasopharyngeal (NP) swab placed into viral transport medium (VTM) is the preferred choice for swab-based SARS-CoV-2 testing. To date, the scientific literature states that nasopharyngeal specimens have the highest yield of recovery of an infected patient. Insert swab through the nostril into the nasopharynx until tip reaches the posterior nasopharynx (a distance equivalent to that from the ear to the nostril of the patient). Leave the swab in place for 10 - 30 seconds. Slowly remove with a rotating motion. Place swab in M4-RT transport medium. |
||||
| Temperature and Stability: | Refrigerated (2-8 degrees C); stable for 72 hours. | ||||
| Unacceptable Conditions: | Frozen samples; Sample obtained on cotton-tipped, wooden- or aluminum-shafted or calcium alginate swabs; Swabs submitted in bacterial transport media (usually clear fluid); Broken, leaking, or unlabeled sample containers; Samples containing swabs other than those provided in the collection kit. | ||||
| Expected Results: | |||||
| Influenza A RNA Detected, Influenza B RNA Detected, SARS-CoV-2 RNA Detected, Not Detected, Invalid | |||||
| Shipping: | |||||
| Wrap specimen container in absorbent material and place inside a biohazard bag. Transport specimen with cold pack. Ship to the Coralville location. | |||||
| Comments | |||||
| Negative Flu SC2 Multiplex Assay results do not preclude SARS-CoV-2, influenza A, and/or influenza B infection and should not be used as the sole basis for diagnosis, treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. | |||||
| Alternate Names | |||||
| Influenza, Influenza A and B, Influenza PCR, SARS-CoV-2 PCR, COVID-19 PCR, 2019 Novel Coronavirus PCR | |||||
